The move strengthens the two organizations’ mission to advance medical science research and education. It also will strengthen the legacy of Nobel Prize winner Herbert A. Hauptman, who led HWI for decades while serving as a UB faculty member.
SUNY invested $425,000 through TAF to fund seven promising projects with the potential to revolutionize healthcare, environmental protection, and New York’s high-tech electronics industry.
The trial showed that adding blina to initial chemotherapy treatment significantly improves survival rates and lowers toxicity levels in newly diagnosed pediatric patients with standard-risk B-cell acute lymphobla stic leukemia with higher-risk features.
Research at SUNY produces more than 200 new technologies every year. SUNY TechConnect is the gateway to world-class SUNY discoveries that are available for licensing and other partnership opportunities.
